Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia
We present an individualized systems medicine (ISM) approach to optimize cancer drug
therapies one patient at a time. ISM is based on (i) molecular profiling and ex vivo drug …
therapies one patient at a time. ISM is based on (i) molecular profiling and ex vivo drug …
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
T Pemovska, M Kontro, B Yadav… - Cancer …, 2013 - researchportal.helsinki.fi
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory
Acute Myeloid Leukemia — University of Helsinki Skip to main navigation Skip to search Skip …
Acute Myeloid Leukemia — University of Helsinki Skip to main navigation Skip to search Skip …
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
T Pemovska, M Kontro, B Yadav, H Edgren… - Cancer …, 2013 - europepmc.org
We present an individualized systems medicine (ISM) approach to optimize cancer drug
therapies one patient at a time. ISM is based on (i) molecular profiling and ex vivo drug …
therapies one patient at a time. ISM is based on (i) molecular profiling and ex vivo drug …
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia
T Pemovska, M Kontro, B Yadav… - Cancer …, 2013 - pubmed.ncbi.nlm.nih.gov
We present an individualized systems medicine (ISM) approach to optimize cancer drug
therapies one patient at a time. ISM is based on (i) molecular profiling and ex vivo drug …
therapies one patient at a time. ISM is based on (i) molecular profiling and ex vivo drug …
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
T Pemovska, M Kontro, B Yadav, H Edgren, S Eldfors… - Cancer …, 2013 - cir.nii.ac.jp
< jats: title> Abstract</jats: title>< jats: p> We present an individualized systems medicine
(ISM) approach to optimize cancer drug therapies one patient at a time. ISM is based on (i) …
(ISM) approach to optimize cancer drug therapies one patient at a time. ISM is based on (i) …
[引用][C] Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia
T Pemovska, B Yadav, M Rämet - CANCER DISCOVERY, 2013 - researchportal.tuni.fi
Individualized systems medicine strategy to tailor treatments for patients with
chemorefractory acute myeloid leukemia — Tampere University Research Portal Skip to …
chemorefractory acute myeloid leukemia — Tampere University Research Portal Skip to …